Adult Patients
Showing 17–32 of 34 results
-
Hypertriglyceridemia Study
Support our research into new Hypertriglyceridemia treatments by getting involved in our study. Your contribution can lead to better management of triglyceride levels.
Read more
Criteria & Qualifications: • Diagnosed with severe Hypertriglyceridemia (SHTG) with high triglyceride levels confirmed by medical records.
• Must be 18 or older with the ability to consent.
• Currently taking medications to lower triglycerides.
Compensation: Contact us for more information -
Hypertriglyceridemia Trial
Be part of our research to develop better Hypertriglyceridemia treatments. Your involvement can help improve triglyceride level management.
Read more
Criteria & Qualifications: • Diagnosed with Hypertriglyceridemia (HTG) and triglyceride levels between 150–499 mg/dL.
• 18 years or older and able to provide consent.
• Willing to follow a low-fat diet during the study.
Compensation: Contact us for more information -
Inflammatory Bowel Disease
Join us in advancing the understanding of treatments for IBD. Help researchers evaluate the safety and effectiveness of approved therapies for Crohn’s disease and Ulcerative Colitis.
Read more
Criteria & Qualifications: • 18 years or older.
• Diagnosed with Crohn’s disease or Ulcerative Colitis.
• Currently using or recently started an approved treatment for IBD.
Compensation: Contact us for more information -
NASH
Participating in this clinical trial can help improve treatments for a liver condition called MASH/NASH, which causes liver damage. The study is testing a new medicine to see if it can help improve liver health for people with moderate to advanced liver fibrosis. Criteria & Qualifications: • Must be 18 years or older. • Diagnosed with MASH/NASH and have moderate to advanced liver fibrosis. • Cannot join if you have other liver diseases or a history of chronic alcohol use. Compensation: Contact us for more information
Read more -
NASH/MASH
Help us improve treatment options for people with NASH and related health conditions. This clinical trial is studying a once-monthly therapy to reduce liver fat and improve metabolic health in diverse populations.
Read more
Criteria & Qualifications: • Adults diagnosed with NASH.
• Includes people with pre-diabetes or type 2 diabetes.
• Open to individuals seeking better liver and metabolic health management.
Compensation: Contact us for more information -
NASH/MASH Study
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH/MASH.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
• Must be weight stable for 6 months.
Compensation: Up to $3,000. -
NASH/MASH Trial
NASH/MASH is a liver disease with inflammation and damage from fat buildup. If you have NASH/MASH, consider participating in our study to help find new treatments.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation: Contact us for more information. -
Obesity
We are conducting a clinical study to evaluate the safety and tolerability of new health interventions. Your participation will help researchers gain valuable insights into improving treatments and overall well-being.
Read more
Criteria & Qualifications: • Ages 18 to 65 years old.
• BMI between 30 and 40 kg/m².
• Non-pregnant females only.
Compensation: Contact us for more information -
Obesity Trial
Join a clinical trial that aims to improve health outcomes for people living with obesity or being overweight. This study is testing a new medication to see how it can reduce health risks and improve the overall quality of life for individuals managing obesity. Criteria & Qualifications: • Must be 18 years or older. • Living with obesity or overweight. • Not currently taking medications for weight loss. Compensation: Contact us for more information
Read more -
Respiratory Syncytial Virus (RSV)
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes. Criteria & Qualifications:
Read more
• Must be 18 years or older.
• Diagnosed with acute RSV infection.
• Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions.
Compensation: Contact us for more information -
Respiratory Syncytial Virus (RSV) Study
Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply. Criteria & Qualifications: • Must be 18 years or older and diagnosed with RSV within the last 5 days. • Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization. • Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition. Compensation: Contact us for more information
Read more -
Sjogren’s Syndrome
Coming Soon! Join our study exploring new treatments for Sjogren's Syndrome. Your participation could help improve life for many suffering from this autoimmune disease.
Read more
Criteria & Qualifications: • Must be diagnosed with Sjogren's Syndrome.
• Aged 18 years or older.
• Able to provide informed consent for participation.
Compensation: Contact us for more information -
Solid Tumor
Support groundbreaking research by participating in our Solid Tumor study. Your involvement could help develop innovative treatments and improve cancer care.
Read more
Criteria & Qualifications: • Diagnosed with cancer and not responding to therapy.
• Aged 18 or older, able to give consent.
• Committed to attend all study visits.
Compensation: Contact us for more information -
Thyroid Eye Disease
Join our study to explore innovative treatments for Thyroid Eye Disease. Your participation could help improve outcomes and advance research in eye health.
Read more
Criteria & Qualifications: • Diagnosed with Thyroid Eye Disease.
• At least 18 years old, able to consent.
• Able to attend all required study visits.
Compensation: Contact us for more information -
Ulcerative Colitis
Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Diagnosed with Ulcerative colitis in the last 3 months.
• Is willing to provide medical records.
• Must have active symptoms, such as rectal bleeding.
Compensation: up to $1,500 -
Ulcerative Colitis Clinical Trial
Ulcerative Colitis, a form of Inflammatory Bowel Disease (IBD), leads to inflammation, ulcers, and stomach discomfort. We are currently running a clinical study to test the effectiveness and safety of a new Alfa Induction Therapy for individuals suffering from Ulcerative Colitis. Criteria & Qualifications: • Must be 18 years old or above. • Recently diagnosed with Ulcerative Colitis within the past 3 months. • Agreeable to submit medical history documentation. Compensation: Contact us for more information
Read more